We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+3.23%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$906M
AUM Growth
+$185M
Cap. Flow
+$148M
Cap. Flow %
16.31%
Top 10 Hldgs %
24.88%
Holding
586
New
69
Increased
148
Reduced
238
Closed
71

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$23.7M
2
DB icon
Deutsche Bank
DB
+$15.9M
3
UNH icon
UnitedHealth
UNH
+$14.4M
4
COR icon
Cencora
COR
+$13.9M
5
OCR
OMNICARE INC
OCR
+$13.7M

Sector Composition

Rank Sector Weight
1 Industrials 17.33%
2 Consumer Discretionary 11.57%
3 Healthcare 7.92%
4 Utilities 7.88%
5 Materials 6.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PETM
576
DELISTED
PETSMART INC
PETM
-160,594
Closed -$13.1M
KWK
577
DELISTED
QUICKSILVER RESOURCES INC
KWK
-126,727
Closed -$25.1K
CMCSK
578
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
-223,498
Closed -$12.9M
RXII
579
DELISTED
GALENA BIOPHARMA INC COM
RXII
-100,000
Closed -$151K
AHD
580
DELISTED
ATLAS ENERGY L P COM UNITS REPSTG LTD PARTNER INT (DE)
AHD
-521
Closed -$16.2K
CELG
581
DELISTED
Celgene Corp
CELG
-52
Closed -$5.82K
QGENF
582
PUT
DELISTED
QIAGEN NV
QGENF
-200
Closed -$9.71K
VXX
583
PUT
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
-31
Closed -$3K
WPZ
584
DELISTED
WILLIAMS PARTNERS L.P. COM UTS REPTG L.P. INT
WPZ
-324
Closed -$13.6K
AGN
585
DELISTED
Allergan Inc
AGN
-423
Closed -$89.9K

Similar funds

Exane Derivatives's Q1 2015 Portfolio in Review

As of Q1 2015, Exane Derivatives held 586 positions worth $906M, up 26% from $721M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Exane Derivatives deployed $148M of net new capital in Q1 2015, opening 69 new positions and adding to 148 existing holdings. Its largest new stake was WEC Energy: 438,756 shares worth $21.7M.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, up from 6.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $23.7M trimmed.

  • Exane Derivatives's largest Q1 2015 buy was WEC Energy: 438,756 shares worth $21.7M.
  • Exane Derivatives added most to Delta Air Lines in Q1 2015, an estimated $23.1M increase.
  • Exane Derivatives's biggest Q1 2015 reduction was Vertex Pharmaceuticals, cutting an estimated $23.7M.
  • Exane Derivatives fully exited O'Reilly Automotive in Q1 2015, selling an estimated $13.3M.
  • Exane Derivatives's ten largest holdings make up 25% of its $906M portfolio in Q1 2015.
  • Exane Derivatives opened 69 new positions and closed 71 in Q1 2015.
  • Exane Derivatives's portfolio value rose 26% quarter-over-quarter to $906M.

Based on Exane Derivatives's 13F filing for Q1 2015, filed 15 May 2015.